Connect
MJA
MJA

Cryptogenic neuropsychiatric presentations diagnostic delay in Cryptococcus gattii meningoencephalitis at a regional Australian tertiary hospital

Andrew P Gador‐Whyte, Jared Harris, Karen Gunanayagam, Aaron Walton, Andrew Hughes and Eugene Athan
Med J Aust 2022; 216 (2): . || doi: 10.5694/mja2.51384
Published online: 7 February 2022

 


  • 1 Barwon Health, Geelong, VIC
  • 2 Deakin University, Geelong, VIC


Correspondence: andrewpgw@gmail.com

Acknowledgements: 

We acknowledge the two patients and their families and their willingness to have their stories shared. We also acknowledge the involvement in the care of these patients of our colleagues in the infectious diseases, neurology, general medicine and several other teams at our health service and at the neurosurgical referral centre.

Competing interests:

No relevant disclosures.

  • 1. Chen SCA, Meyer W, Sorrell TC. Cryptococcus gattii Infections. Clin Microbiol Rev 2014; 27: 980–1024.
  • 2. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 291–322.
  • 3. Liliang PC, Liang CL, Chang WN, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus‐negative patients. Clin Infect Dis 2003; 37: 673–678.
  • 4. Aye C, Henderson A, Yu H, Norton R. Cryptococcosis — the impact of delay to diagnosis. Clin Microbiol Infect 2016; 22: 632–635.
  • 5. Chen SCA, Slavin MA, Heath CH, et al. Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 2012; 55: 789–798.
  • 6. Ecevit IZ, Clancy CJ, Schmalfuss IM, Nguyen MH. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis 2006; 42: 1443–1447.
  • 7. Lui G, Lee N, Ip M, et al. Cryptococcosis in apparently immunocompetent patients. QJM 2006; 99: 143–151.
  • 8. Hughes CM, Lennon D, Davis JS. CRyptOcoccosis in Newcastle and the hUnTer (CRONUT) — an epidemiological study. Infect Dis Health 2020; 25: 34–42.
  • 9. Seelig S, Ryus CR, Harrison RF, et al. Cryptococcal meningoencephalitis presenting as a psychiatric emergency. J Emerg Med 2019; 57: 203–206.
  • 10. Martin RA, Bates D, Shaw DA. Cryptococcal meningoencephalitis. Br Med J 1975; 3: 75–76.
  • 11. Chen CH, Chang CC, Chang WN, et al. Neuro‐psychological sequelae in HIV‐negative cryptococcal meningitis after complete anti‐fungal treatment. Acta Neurol Taiwan 2012; 21: 8–17.
  • 12. Phillips P, Galanis E, MacDougall L, et al. Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia. Clin Infect Dis 2015; 60: 1368–1376.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.